- Home
- PXLW vs TLPH Comparison
PXLW vs TLPH Comparison
Compare PXLW & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PXLW | TLPH |
|---|---|---|
| Founded | 1997 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.0M | 42.3M |
| IPO Year | 2000 | 2010 |
Fundamental Metrics
Financial Performance| Metric | PXLW | TLPH |
|---|---|---|
| Price | $7.09 | $0.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $14.33 | N/A |
| AVG Volume (30 Days) | ★ 164.2K | 145.0K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 12.46 | N/A |
| Revenue | $693,000.00 | ★ $2,151,000.00 |
| Revenue This Year | $47.19 | N/A |
| Revenue Next Year | $30.00 | N/A |
| P/E Ratio | $0.56 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.84 | $0.38 |
| 52 Week High | $15.42 | $1.57 |
Technical Indicators
Market Signals| Indicator | PXLW | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 59.11 | 58.11 |
| Support Level | $5.61 | $0.74 |
| Resistance Level | $7.45 | $0.98 |
| Average True Range (ATR) | 0.43 | 0.05 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 86.86 | 74.87 |
Price Performance
Historical ComparisonAbout PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.